Compare HALO & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
QXO Inc provides technology solutions, primarily to clients in the manufacturing, distribution and service sectors. It provides consulting and professional services, specialized programming, training and technical support also offers solutions for accounting, financial reporting, enterprise resource planning, warehouse management systems, customer relationship management, business intelligence and other applications. Additionally, QXO develops and publishes its own proprietary software.